Disease activity in rheumatoid arthritis and the risk of cardiovascular events

Arthritis & Rheumatology
Daniel H SolomonJ D Greenberg

Abstract

Use of several immunomodulatory agents has been associated with reduced numbers of cardiovascular (CV) events in epidemiologic studies of rheumatoid arthritis (RA). However, it is unknown whether time-averaged disease activity in RA correlates with CV events. We studied patients with RA whose cases were followed in a longitudinal US-based registry. Time-averaged disease activity was assessed during followup using the area under the curve of the Clinical Disease Activity Index (CDAI), a validated measure of RA disease activity. Age, sex, presence of diabetes mellitus, hypertension, or hyperlipidemia, body mass index, family history of myocardial infarction (MI), use of aspirin or nonsteroidal antiinflammatory drugs (NSAIDs), presence of CV disease, and baseline use of an immunomodulator were assessed at baseline. Cox proportional hazards regression models were examined to determine the risk of a composite CV end point that included MI, stroke, and death from CV causes. A total of 24,989 patients who had been followed up for a median of 2.7 years were included in these analyses. During followup, we observed 534 confirmed CV end points, for an incidence rate of 7.8 per 1,000 person-years (95% confidence interval [95% CI] 6.7-8.9)....Continue Reading

References

Nov 18, 2000·Circulation·E Braunwald, M R Bristow
Mar 12, 2003·Circulation·Daniel H SolomonGary C Curhan
Mar 8, 2005·Arthritis and Rheumatism·Hilal Maradit-KremersSherine E Gabriel
Dec 13, 2005·Autoimmunity Reviews·Joel M Kremer
Nov 28, 2008·Arthritis and Rheumatism·J Antonio Aviña-ZubietaDiane Lacaille
Nov 27, 2010·Annals of the Rheumatic Diseases·Jeffrey D GreenbergUNKNOWN CORRONA Investigators
Aug 2, 2011·Annals of the Rheumatic Diseases·Boulos HaraouiUNKNOWN Treat to Target Taskforce
Aug 23, 2011·The American Journal of Cardiology·Renata MichaDariush Mozaffarian

❮ Previous
Next ❯

Citations

Jan 26, 2016·Autoimmunity Reviews·Esther Houri LeviHoward Amital
Mar 1, 2016·Zeitschrift für Rheumatologie·K Krüger
Mar 17, 2016·Autoimmunity Reviews·Zoltán SzekaneczYehuda Shoenfeld
Mar 8, 2016·Expert Review of Clinical Immunology·Barbara TolussoElisa Gremese
Jun 29, 2015·Autoimmunity Reviews·I HollanP L Meroni
Jul 27, 2015·Current Rheumatology Reports·Catherine M McGrath, Stephen P Young
Jul 23, 2016·Seminars in Arthritis and Rheumatism·Christina Charles-SchoemanRichard Riese
Dec 3, 2016·Arthritis Research & Therapy·Jenny HumphreysDeborah Symmons
Mar 18, 2016·Annals of the Rheumatic Diseases·Lotta LjungJohan Askling
Oct 25, 2016·International Emergency Nursing·Lynda Gibbons, Patricia Cunningham
Apr 15, 2017·British Journal of Pharmacology·Paul WelshPasquale Maffia
Dec 17, 2016·Current Opinion in Rheumatology·Rishi J Desai, Daniel H Solomon
Apr 1, 2017·Current Rheumatology Reports·Ann M ChodaraChristie M Bartels
Jul 13, 2017·Community Dentistry and Oral Epidemiology·Karin BäckLars Dahlström
Feb 22, 2018·Current Rheumatology Reports·Jorge Plutzky, Katherine P Liao
Jan 12, 2017·Annals of the Rheumatic Diseases·Audrey S L LowUNKNOWN British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BSRBR-RA) and the BSRBR Control Centre Consort
Oct 11, 2016·Therapeutic Advances in Musculoskeletal Disease·Anne TournadreMartin Soubrier
Nov 7, 2017·Nature Reviews. Drug Discovery·Daniella M SchwartzJohn J O'Shea
Sep 16, 2017·Journal of Thrombosis and Haemostasis : JTH·A B PedersenH T Sørensen
May 12, 2018·Rheumatology International·Helen V UdachkinaEvgenia I Markelova
Feb 4, 2016·Journal of Korean Medical Science·Diana S NovikovaEvgeny L Nasonov
Feb 23, 2019·Medical Sciences : Open Access Journal·Isabel M McFarlaneSrinivas Kolla
Jan 19, 2019·Zeitschrift für Rheumatologie·K Krüger, H Nüßlein
May 3, 2019·Zeitschrift für Rheumatologie·K Krüger, C Kneitz
Jan 17, 2019·The Journal of Rheumatology·Mohammad H DerakhshanUNKNOWN BRITSpA and COMOSPA Investigators
Dec 19, 2018·Journal of the Saudi Heart Association·Mohamed NaseemAbeer Abd Elmonem Shahba

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.